Acute Kidney Injury (AKI) with Complete Recovery
The most likely explanation for an eGFR dropping to 39 mL/min/1.73 m² and then rising to 106 mL/min/1.73 m² three months later is acute kidney injury (AKI) that completely resolved, returning kidney function to baseline or near-baseline levels.
Understanding the Clinical Scenario
This dramatic improvement in eGFR represents a >170% increase from the nadir, which is characteristic of reversible AKI rather than chronic kidney disease (CKD). The KDIGO AKI guidelines define AKI as an acute change in kidney function occurring within 48 hours to 7 days 1, 2. While the guidelines focus on short-term changes, the principle of reversibility extends to recovery periods of weeks to months.
Key Distinguishing Features
The pattern you describe has several important characteristics:
- Magnitude of change: A rise from 39 to 106 mL/min/1.73 m² represents near-complete or complete recovery
- Timeline: Three months is consistent with AKI recovery, particularly for severe cases
- Final eGFR: 106 mL/min/1.73 m² suggests return to normal or near-normal baseline function
Most Common Causes of Reversible AKI
Pre-renal AKI (Most Common)
- Volume depletion: Dehydration, hemorrhage, gastrointestinal losses
- Hypotension: Sepsis, heart failure exacerbation, medications
- Reduced effective circulating volume: Cirrhosis, nephrotic syndrome
Medication-Induced AKI
- NSAIDs: Cause hemodynamic changes affecting glomerular filtration
- ACE inhibitors/ARBs: Particularly with concurrent volume depletion
- Diuretics: Excessive use leading to volume depletion
- SGLT2 inhibitors: Can cause initial eGFR decline of 7-10% that typically recovers 3
Contrast-Induced AKI (CI-AKI)
The guidelines provide specific risk stratification for radiocontrast nephropathy 1. With baseline eGFR 20-40 mL/min/1.73 m², the risk is elevated, but recovery is typical when it occurs.
Acute Tubular Necrosis (ATN)
- Ischemic: From prolonged hypotension or shock
- Nephrotoxic: Aminoglycosides, amphotericin, cisplatin
- Recovery typically occurs over 1-3 months as tubular cells regenerate
Obstruction
- Urinary tract obstruction: Stones, prostatic hypertrophy, malignancy
- Complete recovery expected if obstruction relieved promptly
Critical Pitfalls to Avoid
Laboratory Error or Measurement Issues
Before attributing this to true AKI recovery, verify:
- Creatinine assay method: Different methods (Jaffe vs. enzymatic) can yield different results 2
- Hydration status: Significant volume changes between measurements
- Muscle mass changes: Acute illness with muscle wasting can lower creatinine independent of GFR
- Laboratory error: Repeat measurement to confirm
Acute-on-Chronic Kidney Disease
If the patient had underlying CKD with baseline eGFR around 40-50 mL/min/1.73 m², an acute insult could have temporarily dropped it to 39, with recovery to their baseline (not 106). The final eGFR of 106 argues strongly against this scenario.
Glomerular Hyperfiltration
Research shows that eGFR can fluctuate significantly in certain conditions 4. However, hyperfiltration typically involves gradual changes over years, not acute drops followed by rapid recovery.
Diagnostic Approach
Immediately review:
- Medication history: Any nephrotoxic drugs, diuretics, ACE-I/ARBs, NSAIDs started before the low eGFR?
- Clinical context at time of eGFR 39: Hospitalization? Acute illness? Imaging with contrast? Surgery?
- Volume status: Evidence of dehydration, heart failure, or hypotension?
- Urinalysis from the acute period: Proteinuria, hematuria, casts would suggest intrinsic kidney disease
- Other labs: BUN:Cr ratio >20:1 suggests pre-renal; fractional excretion of sodium if available
If no clear cause identified:
- Consider urinary tract imaging to exclude obstruction (though less likely given complete recovery)
- Review for AKI risk factors per KDIGO staging 1: hypotension, heart failure, sepsis, nephrotoxic exposures
Prognostic Implications
The complete recovery to eGFR 106 is excellent prognostically. Research demonstrates that patients who recover kidney function after AKI have significantly better long-term outcomes 5. However, even with complete recovery, prior AKI increases risk for future CKD, so ongoing monitoring is warranted.
Follow-up Recommendations
- Repeat eGFR in 3-6 months to confirm stability
- Urinalysis to screen for proteinuria or hematuria
- Avoid nephrotoxic exposures when possible
- Optimize cardiovascular risk factors: Hypertension and cardiovascular disease predict rapid eGFR decline 6
Bottom Line
This pattern overwhelmingly suggests reversible AKI with complete recovery. The most common causes are pre-renal azotemia (volume depletion, hypotension) or medication-induced injury. The key is identifying the precipitating event through careful history review of the period when eGFR was 39. The excellent recovery to 106 mL/min/1.73 m² indicates the kidney injury was functional or acute tubular in nature rather than structural/chronic, and the prognosis is favorable with appropriate preventive measures going forward.